Cyclacel Pharmaceuti (CYCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CYCC | AMGN | VRTX | BMY | REGN |
Company | Cyclacel Pharmaceuti | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
Open | 2.37 | 313.39 | 401.50 | 43.90 | 926.94 |
High | 2.52 | 322.60 | 405.67 | 44.33 | 958.13 |
Low | 1.94 | 308.68 | 397.59 | 43.69 | 926.94 |
Last | 2.00 | 311.29 | 401.08 | 43.99 | 957.00 |
Change | -0.49 | +32.90 | +0.92 | +0.29 | +19.39 |
% Change | -19.68% | +11.82% | +0.23% | +0.66% | +2.07% |
Volume | 566,900 | 9,644,601 | 1,064,000 | 12,104,400 | 547,300 |
20-Day Average Volume | 2,372,155 | 2,646,885 | 1,022,600 | 14,464,405 | 518,580 |
Previous Close | 2.49 | 278.39 | 400.16 | 43.70 | 937.61 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.92 | 272.27 | 398.43 | 47.46 | 909.87 |
20-Day Raw Stochastic | 25.93% | 81.73% | 63.17% | 7.87% | 98.64% |
20-Day Relative Strength | 48.67% | 72.10% | 47.14% | 29.25% | 59.08% |
Weighted Alpha | -79.49 | +33.76 | +14.36 | -36.67 | +26.69 |
Today's Opinion | 80% Sell | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
Previous Opinion | 48% Sell | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
Last Month's Opinion | 100% Sell | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
Performance | |||||
5-Days | |||||
%Chg | +32.45% since 04/26/24 | +15.30% since 04/26/24 | +0.91% since 04/26/24 | -1.92% since 04/26/24 | +8.36% since 04/26/24 |
Low | 1.30 on 04/29/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
High | 4.00 on 05/01/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 958.13 on 05/03/24 |
1-Month | |||||
%Chg | -8.68% since 04/03/24 | +13.44% since 04/03/24 | -1.89% since 04/03/24 | -15.70% since 04/03/24 | +0.64% since 04/03/24 |
Low | 1.30 on 04/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
High | 4.00 on 05/01/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
3-Month | |||||
%Chg | -10.31% since 02/02/24 | -3.68% since 02/02/24 | -5.56% since 02/02/24 | -9.69% since 02/02/24 | +1.25% since 02/02/24 |
Low | 1.30 on 04/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
High | 4.00 on 05/01/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -77.05% since 11/03/23 | +15.35% since 11/03/23 | +6.61% since 11/03/23 | -16.72% since 11/03/23 | +17.15% since 11/03/23 |
Low | 1.30 on 04/29/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
High | 10.12 on 11/06/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 2,637 | 166,968,480 | 103,662,736 | 89,172,128 | 105,042,232 |
Shares Outstanding, K | 1,318 | 536,376 | 258,459 | 2,027,100 | 109,762 |
Annual Sales | 420,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
Annual Net Income | -22,560,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
Last Quarter Sales | 30,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
Last Quarter Net Income | -5,270,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
60-Month Beta | 0.54 | 0.60 | 0.39 | 0.45 | 0.17 |
Per-Share Information | |||||
Most Recent Earnings | -6.23 on 03/19/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
Most Recent Dividend | 0.150 on 07/13/16 | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
Next Ex-Dividends Date | 07/13/16 | 05/16/24 | N/A | 04/04/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 41.62 | 25.27 |